IP Library Granted Patent US 9,315,783
Granted Patent B2
US 9,315,783 · App. 14/188,838 · Granted Apr 19, 2016

Codon-optimized gene for mutated shrimp luciferase and method for use thereof

Inventors: Satoshi Inouye (Yokohama, JP); Junichi Sato (Yokohama, JP)
Assignee: JNC CORPORATION
C12N9/0069C12Q1/66C12Y113/12013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,783
App. No.
14/188,838
Granted
Apr 19, 2016
Kind
B2
Abstract

There has been a demand for a codon-optimized gene for the mutated catalytic domain of Oplophorus luciferase, which is capable of efficiently expressing a protein both in a cultured animal cell and Escherichia coli . There has also been a demand for a substrate coelenterazine analogue showing a higher activity than that of native 19 kDa protein. The invention provides a polynucleotide comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2. According to the invention, bis-coelenterazine is used as a substrate coelenterazine analogue suitable for the photoprotein encoded by the polynucleotide comprising the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2.

Claims (21)

1. An isolated polynucleotide selected from the group consisting of (a) to (d) below:

(a) a polynucleotide comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2;

(b) polynucleotide comprising a polynucleotide encoding a protein consisting of a nucleotide sequence in which 1 to 20 nucleotides are deleted, substituted, inserted and/or added in the nucleotide sequence of SEQ ID NO: 2, and having a luminescent catalyst activity by using luciferin as a substrate;

(c) a polynucleotide comprising a polynucleotide encoding a protein consisting of a nucleotide sequence having at least 90% identity to the nucleotide sequence of SEQ ID NO: 2, and having a luminescent catalyst activity by using lucifeuin as a substrate; and,

(d) a polynucleotide comprising a polynucleotide encoding a protein which hybridizes to a polynucleotide consisting of a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 2 under high stringency conditions, and has a luminescent catalyst activity by using luciferin as a substrate, wherein the high stringency conditions are 5×SSC, 5×Denhardt's solution, 0.5% (w/v) SDS, 50% (v/v) formamide, and 50° C.

2. The polynucleotide according to claim 1 , which is selected from the group consisting of (a) to (c) below:

(a) a polynucleotide comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2;

(b) a polynucleotide comprising a polynucleotide encoding a protein consisting of a nucleotide sequence in which 1 to 15 nucleotides are deleted, substituted, inserted and/or added in the nucleotide sequence of SEQ ID NO: 2, and having a luminescent catalyst activity by using luciferin as a substrate; and

(c) a polynucleotide comprising a polynucleotide encoding a protein consisting of a nucleotide sequence having at least 95% identity to the nucleotide sequence of SEQ ID NO: 2, and having a luminescent catalyst activity by using luciferin as a substrate.

3. The polynucleotide according to claim 1 , which is selected from the group consisting of (a) to (c) below:

(a) a polynucleotide comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2;

(b) a polynucleotide comprising a polynucleotide encoding a protein consisting of a nucleotide sequence in which 1 to 10 nucleotides are deleted, substituted, inserted and/or added in the nucleotide sequence of SEQ ID NO: 2, and having a luminescent catalyst activity by using luciferin as a substrate; and,

(c) a polynucleotide comprising a polynucleotide encoding a protein consisting of a nucleotide sequence having at least 98% identity to the nucleotide sequence of SEC) ID NO: 2, and having a luminescent catalyst activity by using luciferin as a substrate.

4. An isolated polynucleotide comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2.

5. The polynucleotide according to claim 1 , further comprising a polynucleotide encoding a polypeptide consisting of an amino acid sequence for promoting translation and/or a polynucleotide encoding a polypeptide consisting of an amino acid sequence for purification.

6. An isolated polynucleotide consisting of any one of the nucleotide sequences of SEQ ID NO: 5, SEQ ID NO: 8, SEQ ID NO: 10 and SEQ ID NO: 14.

7. A recombinant vector comprising the polynucleotide according to claim 1 .

8. An isolated transformed host cell comprising the recombinant vector according to claim 7 .

9. A method of producing a protein, which comprises the step of culturing the transformed host cell according to claim 8 to produce the protein encoded by the polynucleotide.

10. A kit comprising the polynucleotide according to claim 1 , a recombinant vector comprising the polynucleotide or an isolated transformed host cell comprising the vector.

11. The kit according to claim 10 , further comprising bis-coelenterazine.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: JNC CORPORATION
To: PROLUME LTD.
Reel/Frame 063962/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2014
From: INOUYE, SATOSHI; SATO, JUNICHI
To: JNC CORPORATION
Reel/Frame 032289/0487 →
Priority Claims (1)
JP 2013-038350 · Feb 28, 2013 · national
Continuity (1)
Related Publication 20140242574A1 · Aug 28, 2014